PharmaEngine, Inc. (TPEX:4162)
78.00
+1.30 (1.69%)
Aug 12, 2025, 1:30 PM CST
Paramount Global Market Cap
PharmaEngine has a market cap or net worth of 11.02 billion as of August 11, 2025. Its market cap has decreased by -19.77% in one year.
Market Cap
11.02B
Enterprise Value
5.36B
Revenue
2.55B
Ranking
n/a
PE Ratio
6.23
Stock Price
$78.00
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 11.02B, an increase of 104.88%. That is a compound annual growth rate of 5.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 11.02B | -15.06% |
Dec 31, 2024 | 12.97B | -14.41% |
Dec 29, 2023 | 15.16B | -15.60% |
Dec 30, 2022 | 17.96B | 75.96% |
Dec 30, 2021 | 10.21B | 21.08% |
Dec 31, 2020 | 8.43B | -15.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 203.96B |
PharmaEssentia | 169.97B |
Bora Pharmaceuticals Co., LTD. | 88.98B |
Lotus Pharmaceutical | 57.98B |
Oneness Biotech | 31.13B |
Polaris Group | 27.81B |
Center Laboratories | 27.03B |
Pegavision | 24.80B |